Immunocore Holdings Plc ADR (IMCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 75,400 | 70,502 | 69,833 | 65,179 | 59,757 |
| Cost of Goods | 1,707 | 246 | 197 | 279 | 346 |
| Gross Profit | 73,693 | 70,256 | 69,637 | 64,900 | 59,411 |
| Operating Expenses | 90,417 | 96,992 | 100,145 | 66,064 | 73,514 |
| Operating Income | -16,017 | -26,490 | -30,311 | -885 | -13,757 |
| Interest Expense | 4,277 | 3,239 | 564 | 2,066 | 1,274 |
| Other Income | 10,164 | 5,650 | 3,736 | 5,179 | -1,792 |
| Pre-tax Income | -10,130 | -24,079 | -27,139 | 2,228 | -16,823 |
| Income Tax | 1,486 | 357 | -5,905 | -182 | 191 |
| Net Income Continuous | -11,616 | -24,436 | -21,234 | 2,410 | -17,014 |
| Net Income | $-11,616 | $-24,436 | $-21,234 | $2,410 | $-17,014 |
| EPS Basic Total Ops | -0.23 | -0.49 | -0.43 | 0.05 | -0.35 |
| EPS Basic Continuous Ops | -0.23 | -0.49 | -0.43 | 0.05 | -0.35 |
| EPS Diluted Total Ops | -0.23 | -0.49 | -0.43 | 0.05 | -0.35 |
| EPS Diluted Continuous Ops | -0.23 | -0.49 | -0.42 | 0.04 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.49 | -0.40 | 0.04 | -0.37 |
| EBITDA(a) | $-15,025 | $-25,479 | $-31,246 | $2,159 | $-12,728 |